glp-1 news october 21 2025 New Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity GLP-1 receptor agonists and next-generation

Journal of Agricultural and Food Chemistry 52: 8151-8154 (2004) Du Toit WJ, Lisjak K, Stander M, Prevoo D

Another recently completed phase 3 clinical trial called REDEFINE 2 , which included 1,207 adults with type 2 diabetes and overweight or obesity, found that after 68 weeks, CagriSema led to weight loss of almost 16% experts say the highest yet in the type 2 population, compared to other weight management drugs like tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) and semaglutide

C., Christensen, M

Types Used: Q-switched lasers, fractional lasers, and advanced pigmentation lasers

Its unclear what kinds of activity are best at boosting GLP-1, but high-intensity exercises such as running may be particularly beneficial

Bouhlal, S